Xenomics Announces Issuance of a U.S. Patent

Xenomics, Inc. a developer of next-generation medical DNA diagnostic technologies, announced issuance of its U.S. patent “Methods for detection of nucleic acid sequences in urine,” RE39,920, that covers use of its proprietary transrenal nucleic acid technology in the area of infectious disease diagnostics and monitoring.
CNN Money